Perineal Massage Using A Pelvic Wand During Pregnancy

Study Overview and Design This is a randomized controlled, single-center study to assess the effect of the Intimate RoseTM Pelvic Wand device (Figure 1) on the birth experience.

Methods Recruitment We will enroll eligible adult pregnant patients who plan to give birth at BIDMC.

Randomization After providing consent, we will randomize participants in a 1:1 ratio to the intervention or control arm.

Enrollment and Antepartum Period The intervention arm will receive standard of care education about the benefits of perineal massage and receive instruction to perform the massage three times weekly. They will then watch a 2-minute video to demonstrate proper use and cleaning of the device to assist with antepartum perineal massage. Trained study personnel will also be avilable to answer questions on proper use, storage, and cleaning. Participants will be provided with the pelvic wand at enrollment and asked to use the device at least three times weekly for 10 minutes begining at enrollment until their hospitilization for birth. This frequency and duration are what is recommended by pelvic floor physical therapists and is their standard of care.

The control arm will receive standard of care verbal education about the benefits of self-directed (or partner) manual perineal massage in the antepartum period and during the birthing process. They will be given the device after birth before hospital discharge.

Participants will be told to call their primary obstetric provider if they experience any symptoms when using the device or doing manual massage.

Device Use on Labor & Delivery The intervention arm will be asked to utilize the device every hour for at least 5 minutes. The participant will utilize the device until the second stage of labor (the onset of pushing), at which point the provider or bedside nurse can assist the participant in performing the perineal massage, which is the current standard of care on the BIDMC labor and delivery unit.

The control arm will perform perineal massage if they choose; there will be no research interaction with control arm participants on Labor and Delivery. We will give the device to the control arm participants after birth and before discharge in their postpartum room. As with the intervention group, they will be given the 2-minute video to demonstrate propoer use and cleaning, and they will be given an opportunity to ask questions.

Device Use During the Postpartum Period All participants will be asked to use the device at least three times weekly for 10 minutes after they receive clearance from their obstetric provider at their six-week postpartum visit. Study staff will call the participants to remind them on the instructions for use that were previously supplied. Participants will be asked to use the device until 12 weeks postpartum.

Participant Questionaries Participants will be asked to track their use of the device or manual massage and to complete the following questionnaires to assess their birth experience prior to hospital discharge and pelvic floor dysfunction and urinary dysfunction to be assessed at time of enrollment, 6 weeks postpartum, and 3 months postpartum.

• At enrollment and after consent: Pelvic Floor Distress Inventory 20 and Female Sexual Function Index
• During birth hospitalization: Labor Agentry Scale and Pelvic Floor Distress Inventory 20
• Six weeks postpartum: Pelvic Floor Distress Inventory 20
• 12 weeks postpartum: Labor Agentry Scale, Pelvic Floor Distress Inventory 20, Female Sexual Function Index

Inclusion criteria

• Pregnant
• Plan to give birth at BIDMC
• Age ≥18 years old
• English language preference
• 32-36 weeks 'gestation

Exclusion criteria

• Contraindication to vaginal birth, active genital herpes infection, fetal anomaly requiring cesarean birth).